講演情報

[O2-04]FIREFISH:脊髄性筋萎縮症(SMA)I型患者におけるリスジプラムの5年間継続投与時の有効性及び安全性

竹島 泰弘1, Giovanni Baranello2, Riccardo Masson3, Maria Mazurkiewicz-Beldzinska4, Eugenio Mercuri5, Laurent Servais6, Hui Xiong7, Edmar Zanoteli8, Muna El-Khairi9, Marianne Gerber9, Laura Palfreeman9, Basil T Darras10 (1.兵庫医科大学小児科2.Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London, UK, 3.Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy, 4.Department of Developmental Neurology, Medical University of Gdansk, Gdansk, Poland, 5.Pediatric Neurology Institute, Catholic University and Nemo Pediatrico, Fondazione Policlinico Gemelli IRCCS, Rome, Italy, 6.MDUK Oxford Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, United Kingdom, 7.Department of Pediatrics, Peking University First Hospital, Beijing, China, 8.Department of Neurology, Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo, Brazil, 9.F. Hoffmann-La Roche Ltd., Basel, Switzerland, 10.Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA)

閲覧にはパスワードが必要です

抄録パスワード認証
パスワードは、「第67回日本小児神経学会学術集会プログラム・抄録集」(「脳と発達」第57巻学術集会号)に記載してあります。